Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2 March 2009 to 17 March 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Date of Signature: 15/10/2007; Date of Inspection: 21/08/2007
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/Ca (CBA/CaOlaHsd)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8-12 weeks old.
- Weight at study initiation: 15-23 grams.
- Housing: Suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet: Ad libitum.
- Water: Ad libitum.
- Acclimation period: At least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25 °C.
- Humidity (%): 30-70%.
- Air changes (per hr): Approximately 15 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hours dark/12 hours light.
IN-LIFE DATES: From: Day 1 To: Day 6 - Vehicle:
- other: 1% pluronic L92 in distilled water.
- Concentration:
- Preliminary Screening Test: 10% w/w
Main test: 2.5%, 5% & 10% - No. of animals per dose:
- Preliminary Screening Test: 10% w/w - 1 mouse
Main test: Vehicle control - 4 mice; 2.5% - 4 mice; 5% - 4 mice; 10% - 4 mice - Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: 1% pluronic L92 in distilled water was chosen as the vehicle as it produced the highest concentration that was suitable for dosing.
- Irritation: REFER BACK TO IRRITATION STUDY.
- Lymph node proliferation response: No signs of systemic toxicity.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay in the Mouse.
- Criteria used to consider a positive response: The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitiser".
TREATMENT PREPARATION AND ADMINISTRATION:
For the purpose of the study, the test material was freshly prepared as a solution in 1% pluronic L92 in distilled water.
The mice were treated by daily application of 25 µL of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. - Positive control substance(s):
- other: 2,4-Dinitrobenzenesulfonic acid.
- Statistics:
- The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegrations per minute/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (stimulation Index).
- Positive control results:
- Concentration (% w/w) in 1 % pluronic L92 in distilled water: 10
Stimulation Index: 13.71
Result: Positive - Key result
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- Concentration (% w/w) in 1% pluronic L92 in distilled water
- Remarks on result:
- other: See Table 2.
- Key result
- Parameter:
- SI
- Value:
- 1.01
- Test group / Remarks:
- Concentration (% w/w) in 1% pluronic L92 in distilled water
- Remarks on result:
- other:
- Remarks:
- See Table 2
- Key result
- Parameter:
- SI
- Value:
- 1.58
- Test group / Remarks:
- Concentration (% w/w) in 1% pluronic L92 in distilled water
- Remarks on result:
- other:
- Remarks:
- See Table 2
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Executive summary:
A study was performed to assess the skin sensitisation potential of the test material in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was designed to meet the requirements of the following: OECD Guideline for the Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay" (adopted 24 April 2002); and Method B42 Skin Sensitisation (Local Lymph Node Assay) of Commission Directive 2004/73/EC.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 10 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test material as a solution in 1 % pluronic L92 in distilled water at concentrations of 10 %,5 % or 2.5 % w/w. A further group of four animals was treated with 1 % pluronic L92 in distilled water alone.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (% w/w) in
1 % pluronic L92 in distilled waterStimulation Index
Result
2.5
0.90
Negative
5
1.01
Negative
10
1.58
Negative
Under the conditions of the test, exposure to the test material did not cause a threefold or greater increase in 3HTdR incorporation compared to control values and the stimulation index remained < 3 at all concentrations tested. The test material is considered to be not sensitising in accordance with the OECD guideline.
Reference
Preliminary Screening Test
Clinical observations, bodyweight and mortality data are given in Table 1.
No signs of systemic toxicity were noted.
Based on this information the dose levels selected for the main test were 10 %, 5 % and 2.5 % w/w in 1 % pluronic L92 in distilled water.
Main Test
Estimation of the Proliferative Response of Lymph Node Cells
The radioactive disintegrations per minute per lymph node and the stimulation index are given in Table 2.
A stimulation index of less than 3 was recorded for the three concentrations of the test material (10 %, 5 % and 2.5 % w/w in 1 % pluronic L92 in distilled water).
Clinical Observations and Mortality Data
Individual clinical observations and mortality data for test and control animals are given in Table 3.
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
Bodyweight
Individual bodyweights and bodyweight changes for test and control animals are given in Table 4.
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Table 1: Clinical Observations, Bodyweight and Mortality Data – Preliminary Screening Test
Concentration (% w/w) in 1 % pluronic L92 in distilled water |
Animal Number |
Body weight (g) |
Day |
||||||||||||
Day 1 |
Day 6 |
1 |
2 |
3 |
4 |
5 |
6 |
||||||||
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
||||
10 |
S-1 |
18 |
18 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 = No signs of systemic toxicity
Table 2: Disintegrations per Minute, Disintegrations per Minute/Node and Stimulation Index
Concentration |
dpm |
dpm/Nodea |
Stimulation Indexb |
Result |
Vehicle |
2423.64 |
302.96 |
na |
na |
2.5 |
2181.70 |
272.71 |
0.90 |
Negative |
5 |
2456.92 |
307.12 |
1.01 |
Negative |
10 |
3833.08 |
479.14 |
1.58 |
Negative |
dpm = Disintegrations per minute
a = Disintegrations per minute/node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes)
b = Stimulation Index of 3.0 or greater indicates a positive result
na = Not applicable
Table 3: Individual Clinical Observations and Mortality Data
Concentration (% w/w) in 1 % pluronic L92 in distilled water |
Animal Number |
Day |
|||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
||||||||
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
||
Vehicle |
1-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
1-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
1-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2.5 |
2-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
2-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
5 |
3-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
10 |
4-1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4-2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-4 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 = No signs of systemic toxicity
Table 4: Individual Bodyweights and Bodyweight Changes
Concentration (% w/w) in 1 % pluronic L92 in distilled water |
Animal Number |
Body weight (g) |
Body weight Change (g) |
|
Day 1 |
Day 6 |
|||
Vehicle |
1-1 |
15 |
14 |
-1 |
1-2 |
19 |
19 |
0 |
|
1-3 |
19 |
19 |
0 |
|
1-4 |
18 |
19 |
1 |
|
2.5 |
2-1 |
18 |
19 |
1 |
2-2 |
18 |
19 |
1 |
|
2-3 |
20 |
20 |
0 |
|
2-4 |
18 |
19 |
1 |
|
5 |
3-1 |
19 |
20 |
1 |
3-2 |
19 |
19 |
0 |
|
3-3 |
18 |
19 |
1 |
|
3-4 |
18 |
18 |
0 |
|
10 |
4-1 |
17 |
18 |
1 |
4-2 |
18 |
19 |
1 |
|
4-3 |
18 |
19 |
1 |
|
4-4 |
19 |
19 |
0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In the key study Bradshaw (2009) the skin sensitisation potential of the test material was determined using CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was designed to meet the requirements of the following: OECD Guideline for the Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay" (adopted 24 April 2002); and Method B42 Skin Sensitisation (Local Lymph Node Assay) of Commission Directive 2004/73/EC.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 10 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test material as a solution in 1 % pluronic L92 in distilled water at concentrations of 10 %,5 % or 2.5 % w/w. A further group of four animals was treated with 1 % pluronic L92 in distilled water alone.
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (% w/w) in
1 % pluronic L92 in distilled waterStimulation Index
Result
2.5
0.90
Negative
5
1.01
Negative
10
1.58
Negative
Under the conditions of the test, exposure to the test material did not cause a threefold or greater increase in 3HTdR incorporation compared to control values and the stimulation index remained < 3 at all concentrations tested. The test material is considered to be not sensitising in accordance with the OECD guideline.
Migrated from Short description of key information:
Skin sensitisation = not sensitising, LLNA, OECD 429, Bradshaw (2009).
Justification for selection of skin sensitisation endpoint:
This study was performed under GLP conditions and in accordance with standardised guidelines. It was assigned a reliability score of 1 in accordance with the criteria outlined in Klimisch (1997). It was therefore considered suitable to be the key study for this endpoint.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Skin sensitisation:
According to the criteria outlined in Regulation (EC) No. 1272/2008, the test material does not meet the criteria for classification for skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.